Allogeneic Transforming Growth Factor-beta Receptor Type 2 Knockout CD70 CAR NK Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogeneic Transforming Growth Factor-beta Receptor Type 2 Knockout CD70 CAR NK Cells, covering 2025-10-07 to 2025-10-07. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Study of Allogeneic Transforming Growth Factor-beta Receptor Type 2 Knockout CD70 CAR NK Cells in Treatment Refractory Clear Cell Renal Cell Carcinoma [Phase 1]